Status:
RECRUITING
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Conquer Cancer Foundation
American Society of Clinical Oncology
Conditions:
Malignant Female Reproductive System Neoplasm
Gynecologic Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients wit...
Detailed Description
PRIMARY OBJECTIVE: I. Assess the risk factors associated with frailty in newly diagnosed gynecologic cancer participants. SECONDARY OBJECTIVES: I. Compare primary quality of life endpoint of "healt...
Eligibility Criteria
Inclusion
- Age 18 years or greater
- Undergoing evaluation for a newly diagnosed gynecologic malignancy
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it
Exclusion
- Contraindication to any study-related procedure or assessment
- Does not speak a language for which the consent form and study materials are available
Key Trial Info
Start Date :
October 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2033
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT06089083
Start Date
October 18 2023
End Date
November 30 2033
Last Update
August 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143
2
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215